Repligen Company Leadership
| RGEN Stock | USD 142.18 2.52 1.80% |
About 59% of Repligen's corporate insiders are selling. The analysis of insiders' sentiment of trading Repligen stock suggests that many insiders are alarmed at this time. Repligen employs about 1.8 K people. The company is managed by 24 executives with a total tenure of roughly 33 years, averaging almost 1.0 years of service per executive, having 74.08 employees per reported executive.
| Anthony Hunt CEO President CEO, Director |
| Ralf Kuriyel President Senior Vice President - Research & Development |
Insider Sentiment 41
Mostly Selling
Selling | Buying |
Latest Trades
| 2025-12-17 | Karen A Dawes | Disposed 275 @ 161 | View | ||
| 2025-11-18 | James Bylund | Disposed 2191 @ 151.21 | View | ||
| 2025-11-13 | Anthony Hunt | Disposed 20000 @ 154.61 | View | ||
| 2025-11-12 | Anthony Hunt | Disposed 25000 @ 156.88 | View | ||
| 2025-10-31 | Lisa C. McClain | Disposed @ 149.06 | |||
| 2025-10-30 | Lisa C. McClain | Acquired @ 144.57 | |||
| 2025-08-08 | Martin D Madaus | Acquired 1800 @ 112.13 | View | ||
| 2025-07-22 | Lisa C. McClain | Acquired @ 114.12 | |||
| 2025-06-17 | Lisa C. McClain | Disposed @ 121.01 | |||
| 2025-06-11 | Lisa C. McClain | Acquired @ 132 | |||
| 2025-04-07 | Jefferson Shreve | Disposed @ 116.11 | |||
| 2025-03-17 | Margaret Pax | Acquired 250 @ 150.69 | View |
Monitoring Repligen's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Acquired vs Disposed
Filed vs Not Filed
Insider sentiment refers to the collective sentiment or feeling of Repligen's insiders - typically its officers, directors, and beneficial owners holding more than a certain percentage of the company's stock - about the future prospects of Repligen. This sentiment is often gauged based on the trading activities of these insiders. If insiders are purchasing more shares of their own company, it may be interpreted as a bullish sentiment, indicating that they believe Repligen's stock will rise in value. Conversely, if insiders are selling shares, it might be seen as bearish, suggesting they expect the stock price to drop.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Repligen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in services. Repligen's Workforce Through the Years
Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Repligen's future performance. Based on our forecasts, it is anticipated that Repligen will maintain a workforce of about 1780 employees by March 2026.Repligen Management Team Effectiveness
The company has return on total asset (ROA) of 0.013 % which means that it generated a profit of $0.013 on every $100 spent on assets. This is way below average. Repligen's management efficiency ratios could be used to measure how well Repligen manages its routine affairs as well as how well it operates its assets and liabilities. As of the 7th of February 2026, Return On Tangible Assets is likely to drop to -0.02. In addition to that, Return On Capital Employed is likely to drop to -0.01. At this time, Repligen's Net Tangible Assets are very stable compared to the past year. As of the 7th of February 2026, Intangibles To Total Assets is likely to grow to 0.50, while Non Currrent Assets Other are likely to drop about 742.1 K.As of the 7th of February 2026, Common Stock Shares Outstanding is likely to grow to about 67.5 M. Also, Net Income Applicable To Common Shares is likely to grow to about 224.5 MThe majority of Repligen outstanding shares are owned by third-party entities. These institutional holders are usually referred to as non-private investors looking to secure positions in Repligen to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Repligen. Please pay attention to any change in the institutional holdings of Repligen as this could imply that something significant has changed or is about to change at the company.
Shares in Circulation | First Issued 1985-09-30 | Previous Quarter 56.5 M | Current Value 56.5 M | Avarage Shares Outstanding 28.5 M | Quarterly Volatility 15.7 M |
Repligen Workforce Comparison
Repligen is rated below average in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 183,599. Repligen maintains roughly 1,778 in number of employees contributing less than 1% to equities under Health Care industry.
Repligen Insider Trading History
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Repligen insiders, such as employees or executives, is commonly permitted as long as it does not rely on Repligen's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Repligen insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
| Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
|---|---|---|---|---|---|
| 2025-12-01 | 0.2778 | 5 | 18 | 37,636 | 82,755 |
| 2025-09-01 | 0.4444 | 4 | 9 | 29,856 | 52,029 |
| 2025-06-01 | 2.6667 | 16 | 6 | 22,184 | 26,901 |
| 2025-03-01 | 0.6 | 12 | 20 | 89,844 | 73,812 |
| 2024-12-01 | 1.25 | 5 | 4 | 91,108 | 44,474 |
| 2024-09-01 | 0.8889 | 8 | 9 | 64,259 | 60,007 |
| 2024-06-01 | 2.4444 | 22 | 9 | 27,639 | 21,384 |
| 2024-03-01 | 0.963 | 26 | 27 | 94,399 | 46,816 |
| 2023-12-01 | 1.0 | 2 | 2 | 37,142 | 4,788 |
| 2023-09-01 | 4.0 | 4 | 1 | 30,811 | 850.00 |
| 2023-06-01 | 4.25 | 17 | 4 | 17,066 | 2,088 |
| 2023-03-01 | 1.1176 | 19 | 17 | 114,598 | 35,994 |
| 2022-12-01 | 4.0 | 4 | 1 | 50,932 | 25,000 |
| 2022-09-01 | 1.2727 | 14 | 11 | 33,358 | 53,098 |
| 2022-06-01 | 1.7778 | 16 | 9 | 25,152 | 16,809 |
| 2022-03-01 | 1.087 | 25 | 23 | 118,226 | 39,063 |
| 2021-12-01 | 0.2333 | 7 | 30 | 21,208 | 42,411 |
| 2021-09-01 | 0.2368 | 9 | 38 | 66,735 | 66,371 |
| 2021-06-01 | 0.8824 | 15 | 17 | 28,768 | 49,941 |
| 2021-03-01 | 0.2 | 11 | 55 | 33,478 | 97,842 |
| 2020-12-01 | 0.3846 | 5 | 13 | 26,847 | 52,567 |
| 2020-09-01 | 0.4444 | 4 | 9 | 54,569 | 103,797 |
| 2020-06-01 | 0.4912 | 28 | 57 | 132,763 | 240,186 |
| 2020-03-01 | 0.3864 | 17 | 44 | 97,551 | 177,901 |
| 2019-12-01 | 0.6667 | 2 | 3 | 3,957 | 4,252 |
| 2019-09-01 | 0.0833 | 1 | 12 | 20,000 | 35,989 |
| 2019-06-01 | 1.7778 | 16 | 9 | 79,405 | 60,295 |
| 2019-03-01 | 1.0909 | 12 | 11 | 109,142 | 48,437 |
| 2018-12-01 | 0.5714 | 4 | 7 | 31,753 | 65,580 |
| 2018-09-01 | 0.3333 | 5 | 15 | 16,301 | 237,568 |
| 2018-06-01 | 0.75 | 15 | 20 | 78,022 | 518,257 |
| 2018-03-01 | 1.2 | 12 | 10 | 620,835 | 49,657 |
| 2017-12-01 | 0.6 | 3 | 5 | 12,729 | 925,458 |
| 2017-06-01 | 12.0 | 12 | 1 | 23,373 | 2,275 |
| 2017-03-01 | 1.0667 | 16 | 15 | 303,765 | 74,292 |
| 2016-09-01 | 0.5 | 1 | 2 | 20,000 | 3,024 |
| 2016-06-01 | 2.125 | 17 | 8 | 68,062 | 51,493 |
| 2016-03-01 | 2.0 | 10 | 5 | 178,940 | 6,484 |
| 2015-12-01 | 3.0 | 3 | 1 | 7,000 | 5,000 |
| 2015-09-01 | 1.0 | 1 | 1 | 24,000 | 325.00 |
| 2015-06-01 | 1.4 | 14 | 10 | 26,388 | 232,625 |
| 2015-03-01 | 1.25 | 10 | 8 | 119,519 | 128,483 |
| 2014-12-01 | 0.625 | 5 | 8 | 62,000 | 126,158 |
| 2014-09-01 | 1.0 | 3 | 3 | 20,000 | 45,000 |
| 2014-06-01 | 0.9459 | 35 | 37 | 514,181 | 589,312 |
| 2014-03-01 | 10.0 | 10 | 1 | 142,524 | 40,000 |
| 2013-09-01 | 0.3333 | 1 | 3 | 50,000 | 109,858 |
| 2013-06-01 | 0.5455 | 18 | 33 | 310,016 | 504,087 |
| 2013-03-01 | 1.2857 | 9 | 7 | 385,000 | 179,973 |
| 2012-09-01 | 0.3333 | 8 | 24 | 102,000 | 400,000 |
| 2012-03-01 | 0.3846 | 5 | 13 | 160,000 | 341,551 |
| 2011-09-01 | 2.0 | 2 | 1 | 31,000 | 25,000 |
| 2011-03-01 | 0.25 | 1 | 4 | 5,000 | 85,000 |
| 2009-09-01 | 1.25 | 5 | 4 | 104,000 | 451,800 |
| 2008-09-01 | 3.0 | 6 | 2 | 109,000 | 10,000 |
| 2008-03-01 | 0.1304 | 3 | 23 | 115,000 | 76,368 |
| 2007-12-01 | 0.5556 | 10 | 18 | 155,400 | 92,600 |
| 2007-09-01 | 3.5 | 7 | 2 | 860,000 | 139,465 |
| 2007-06-01 | 1.2857 | 9 | 7 | 127,000 | 89,444 |
| 2007-03-01 | 0.3571 | 5 | 14 | 160,000 | 78,000 |
| 2006-09-01 | 2.2 | 11 | 5 | 108,000 | 65,000 |
| 2006-03-01 | 0.8333 | 15 | 18 | 596,500 | 236,400 |
| 2005-12-01 | 2.0 | 6 | 3 | 17,000 | 36,576 |
| 2005-09-01 | 0.4615 | 6 | 13 | 85,000 | 60,425 |
| 2005-06-01 | 6.0 | 6 | 1 | 175,000 | 15,000 |
| 2005-03-01 | 2.5 | 5 | 2 | 45,000 | 20,000 |
| 2004-09-01 | 6.0 | 6 | 1 | 85,000 | 24,000 |
| 2004-06-01 | 1.75 | 7 | 4 | 220,000 | 25,000 |
| 2004-03-01 | 0.5 | 1 | 2 | 5,000 | 5,000 |
| 2003-12-01 | 1.25 | 20 | 16 | 140,000 | 128,000 |
Repligen Notable Stakeholders
A Repligen stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Repligen often face trade-offs trying to please all of them. Repligen's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Repligen's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Anthony Hunt | President CEO, Director | Profile | |
| Olivier Loeillot | President Officer | Profile | |
| Ralf Kuriyel | Senior Vice President - Research & Development | Profile | |
| Mark Salerno | VP Analytics | Profile | |
| Christine Gebski | Senior Chromatography | Profile | |
| Kimberly Cornwell | General Counsel | Profile | |
| Dianne Heiler | Senior Sustainability | Profile | |
| James Bylund | Chief Officer | Profile | |
| Kola Otitoju | Senior Development | Profile | |
| Stephen Tingley | VP Sales | Profile | |
| Jaime Humara | Senior Marketing | Profile | |
| George Scott | Senior Counsel | Profile | |
| Jon Snodgres | Chief Officer | Profile | |
| Rachel Goodrich | VP Marketing | Profile | |
| Neil Whitfield | Senior Sales | Profile | |
| Leslie Galvin | Global Resources | Profile | |
| Michael Martino | Chief Officer | Profile | |
| Keith Robinson | Chief Officer | Profile | |
| Sondra Newman | Global Relations | Profile | |
| Jason Garland | Chief Officer | Profile | |
| Teresa Ferragamo | Senior Marketing | Profile | |
| Violetta Hughes | Chief Officer | Profile | |
| Jacob CFA | Vice Relations | Profile | |
| Craig Harrison | VP Analytics | Profile |
About Repligen Management Performance
The success or failure of an entity such as Repligen often depends on how effective the management is. Repligen management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Repligen management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Repligen management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.02) | (0.02) | |
| Return On Capital Employed | (0.01) | (0.01) | |
| Return On Assets | (0.01) | (0.01) | |
| Return On Equity | (0.01) | (0.01) |
Repligen Workforce Analysis
Traditionally, organizations such as Repligen use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Repligen within its industry.Repligen Manpower Efficiency
Return on Repligen Manpower
| Revenue Per Employee | 356.8K | |
| Revenue Per Executive | 26.4M | |
| Net Loss Per Employee | 14.3K | |
| Net Loss Per Executive | 1.1M | |
| Working Capital Per Employee | 528.3K | |
| Working Capital Per Executive | 39.1M |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Repligen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in services. To learn how to invest in Repligen Stock, please use our How to Invest in Repligen guide.You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Will Life Sciences Tools & Services sector continue expanding? Could Repligen diversify its offerings? Factors like these will boost the valuation of Repligen. Anticipated expansion of Repligen directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Repligen data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 1.6 | Earnings Share 0.01 | Revenue Per Share | Quarterly Revenue Growth 0.219 | Return On Assets |
Investors evaluate Repligen using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Repligen's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Repligen's market price to deviate significantly from intrinsic value.
It's important to distinguish between Repligen's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Repligen should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Repligen's market price signifies the transaction level at which participants voluntarily complete trades.